vs
Side-by-side financial comparison of ADVANCE AUTO PARTS INC (AAP) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
ADVANCE AUTO PARTS INC is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 0.3%, a 4.1% gap on every dollar of revenue. On growth, ADVANCE AUTO PARTS INC posted the faster year-over-year revenue change (130.1% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-21.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -15.7%).
Advance Auto Parts, Inc. is an American automotive aftermarket parts provider. Headquartered in Raleigh, North Carolina, it serves professional installer and do it yourself (DIY) customers.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
AAP vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.5B |
| Net Profit | $6.0M | $66.5M |
| Gross Margin | 44.1% | 90.5% |
| Operating Margin | 2.2% | 12.4% |
| Net Margin | 0.3% | 4.4% |
| Revenue YoY | 130.1% | 32.8% |
| Net Profit YoY | 101.4% | 143.8% |
| EPS (diluted) | $0.10 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $1.5B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $2.1B | $1.1B | ||
| Q3 24 | $2.2B | $1.0B | ||
| Q2 24 | $2.8B | $929.2M |
| Q1 26 | $6.0M | — | ||
| Q4 25 | $-1.0M | $66.5M | ||
| Q3 25 | $15.0M | $124.8M | ||
| Q2 25 | $24.0M | $94.3M | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | $-6.0M | $-151.9M | ||
| Q3 24 | $45.0M | $-121.3M | ||
| Q2 24 | $40.0M | $-120.4M |
| Q1 26 | 44.1% | — | ||
| Q4 25 | 43.3% | 90.5% | ||
| Q3 25 | 43.5% | 86.1% | ||
| Q2 25 | 42.9% | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | 42.3% | 85.8% | ||
| Q3 24 | 43.6% | 83.0% | ||
| Q2 24 | 43.4% | 85.1% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.1% | 12.4% | ||
| Q3 25 | 1.1% | 11.5% | ||
| Q2 25 | -5.1% | 6.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | -7.0% | ||
| Q3 24 | 2.5% | -12.0% | ||
| Q2 24 | 1.9% | -11.5% |
| Q1 26 | 0.3% | — | ||
| Q4 25 | -0.0% | 4.4% | ||
| Q3 25 | 0.7% | 8.8% | ||
| Q2 25 | 0.9% | 7.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | -0.3% | -13.5% | ||
| Q3 24 | 2.1% | -12.1% | ||
| Q2 24 | 1.4% | -13.0% |
| Q1 26 | $0.10 | — | ||
| Q4 25 | $-0.02 | $0.05 | ||
| Q3 25 | $0.25 | $0.08 | ||
| Q2 25 | $0.40 | $0.06 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | $-0.10 | $-0.10 | ||
| Q3 24 | $0.75 | $-0.09 | ||
| Q2 24 | $0.67 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.1B | $4.5B |
| Total DebtLower is stronger | $3.4B | $836.4M |
| Stockholders' EquityBook value | $2.2B | $4.4B |
| Total Assets | $11.8B | $8.2B |
| Debt / EquityLower = less leverage | 1.55× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.2B | $4.5B | ||
| Q3 25 | $1.7B | $4.0B | ||
| Q2 25 | $1.7B | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | $464.5M | $2.6B | ||
| Q3 24 | $479.4M | $2.7B | ||
| Q2 24 | $451.0M | $2.6B |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $836.4M | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $4.4B | ||
| Q3 25 | $2.2B | $4.1B | ||
| Q2 25 | $2.2B | $3.8B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | $2.6B | $3.3B | ||
| Q3 24 | $2.6B | $3.4B | ||
| Q2 24 | $2.6B | $3.4B |
| Q1 26 | $11.8B | — | ||
| Q4 25 | $12.1B | $8.2B | ||
| Q3 25 | $10.5B | $7.6B | ||
| Q2 25 | $10.6B | $6.3B | ||
| Q1 25 | — | $5.8B | ||
| Q4 24 | $12.5B | $5.9B | ||
| Q3 24 | $12.3B | $5.8B | ||
| Q2 24 | $12.2B | $5.7B |
| Q1 26 | 1.55× | — | ||
| Q4 25 | 1.55× | 0.19× | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.70× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $72.0M | $417.3M |
| Free Cash FlowOCF − Capex | $-21.0M | $379.8M |
| FCF MarginFCF / Revenue | -1.1% | 25.4% |
| Capex IntensityCapex / Revenue | 4.7% | 2.5% |
| Cash ConversionOCF / Net Profit | 12.00× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-298.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.0M | — | ||
| Q4 25 | $-12.0M | $417.3M | ||
| Q3 25 | $50.0M | $402.6M | ||
| Q2 25 | $-156.0M | $263.6M | ||
| Q1 25 | — | $44.1M | ||
| Q4 24 | $70.0M | $75.2M | ||
| Q3 24 | $85.0M | $188.4M | ||
| Q2 24 | $3.0M | $-95.6M |
| Q1 26 | $-21.0M | — | ||
| Q4 25 | $-76.0M | $379.8M | ||
| Q3 25 | $-3.0M | $354.5M | ||
| Q2 25 | $-198.0M | $219.8M | ||
| Q1 25 | — | $-12.3M | ||
| Q4 24 | $27.0M | $-17.3M | ||
| Q3 24 | $44.0M | $54.7M | ||
| Q2 24 | $-43.0M | $-205.5M |
| Q1 26 | -1.1% | — | ||
| Q4 25 | -3.7% | 25.4% | ||
| Q3 25 | -0.1% | 25.1% | ||
| Q2 25 | -7.7% | 16.7% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | 1.3% | -1.5% | ||
| Q3 24 | 2.0% | 5.5% | ||
| Q2 24 | -1.6% | -22.1% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 3.1% | 2.5% | ||
| Q3 25 | 2.6% | 3.4% | ||
| Q2 25 | 1.6% | 3.3% | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | 2.0% | 8.2% | ||
| Q3 24 | 1.9% | 13.3% | ||
| Q2 24 | 1.7% | 11.8% |
| Q1 26 | 12.00× | — | ||
| Q4 25 | — | 6.28× | ||
| Q3 25 | 3.33× | 3.22× | ||
| Q2 25 | -6.50× | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 0.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
